Colombia Celebrates Massive Hep C Price Fall Thanks to Joint Procurement
Executive Summary
Colombian authorities have welcomed savings of 90% for hepatitis C treatments thanks to a pooled procurement initiative supported by the Pan American Health Organization.
You may also be interested in...
Joint Price Negotiations Move Ahead In Latin America
Latin American countries are continuing to pursue a strategy of jointly negotiating medicine prices to get a better deal on expensive medicines. However, manufacturers have expressed doubt that this is the best way forward.
Mercosur Bets On Joint Pricing Negotiations And Procurement For Lower Prices, But Slams Hep C Companies
Countries in South America have negotiated lower prices for the immunosuppressant tacrolimus and have their sights on high-cost oncology treatments. However, they have slammed companies selling new hepatitis C treatments for their inflexibility.
PhRMA Wades In Over Colombian Hep C Declaration Of Public Interest
Declaring hepatitis C drugs to be of public interest would establish a dangerous precedent, PhRMA, the US pharma industry association has warned the Colombian health ministry.